Effect of probiotic versus placebo on non-bacterial infections of the upper respiratory system in infants
Phase 3
- Conditions
- on-bacterial infections of the upper respiratory system.Disease of upper respiratory tract, unspecifiedJ39.9
- Registration Number
- IRCT20120215009014N521
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 450
Inclusion Criteria
Infants 6 to 12 months
Nonbacterial upper respiratory tract inflammation
Exclusion Criteria
Respiratory tract infection
Immune system defect
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity and duration of clinical signs and symptoms of non-bacterial upper respiratory system infections. Timepoint: Before the intervention and one week later. Method of measurement: By taking history and clinical examination.;Duration of hospitalization. Timepoint: After the intervention. Method of measurement: By examining the patient's medical record.
- Secondary Outcome Measures
Name Time Method